Published in Cancer Res on April 05, 2017
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell (2005) 14.21
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev (2010) 3.37
KRAS and YAP1 converge to regulate EMT and tumor survival. Cell (2014) 3.06
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res (2008) 2.96
The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer (2015) 2.74
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell (2014) 2.50
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res (2010) 2.43
eIF5A promotes translation of polyproline motifs. Mol Cell (2013) 2.04
Targeting the translation machinery in cancer. Nat Rev Drug Discov (2015) 1.98
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal (2014) 1.61
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res (2009) 1.46
Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas (2010) 1.27
Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci U S A (2010) 1.27
KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Res (2012) 1.22
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun (2014) 1.22
Alternative Wnt Signaling Activates YAP/TAZ. Cell (2015) 1.21
Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer. Biochem Biophys Res Commun (2013) 1.17
The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol (2014) 1.14
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev (2015) 1.13
eIF5A isoforms and cancer: two brothers for two functions? Amino Acids (2011) 1.09
Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett (2013) 1.08
Embryonic stem cell factors and pancreatic cancer. World J Gastroenterol (2014) 1.03
Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. PLoS One (2012) 1.02
Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer. Stem Cells (2015) 0.96
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer Res (2014) 0.92
Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation. Semin Cell Dev Biol (2016) 0.92
Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prev Res (Phila) (2014) 0.91
PEAK1, a novel kinase target in the fight against cancer. Oncotarget (2010) 0.88
Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels. J Biol Chem (2015) 0.88
The translation factor eIF5A and human cancer. Biochim Biophys Acta (2015) 0.87
Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover. J Biol Chem (2012) 0.86
Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci Rep (2015) 0.85
YAP1 takes over when oncogenic K-Ras slumbers. Cell (2014) 0.85
The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling. Mol Cancer (2015) 0.85
Translational control of eIF5A in various diseases. Amino Acids (2011) 0.84
Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway. Mol Med Rep (2014) 0.82
PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. PLoS One (2015) 0.82
Polyamines in Eukaryotes, Bacteria, and Archaea. J Biol Chem (2016) 0.82
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. Gastroenterology (2016) 0.81
YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells. Stem Cells (2015) 0.81
Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma. Discov Med (2015) 0.81
Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer. Amino Acids (2016) 0.79